Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
about
Genes, tolerance and systemic autoimmunityDicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieuActive systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1Human T regulatory cell therapy: take a billion or so and call me in the morningDisturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus ErythematosusSelected Aspects in the Pathogenesis of Autoimmune DiseasesEmerging and Novel Functions of Complement Protein C1qRegulatory T cell: a protection for tumour cellsFollicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?The role of adenosinergic pathway in human autoimmune diseasesIncreased Foxp3(+) CD4(+) regulatory T cells with intact suppressive activity but altered cellular localization in murine lupusLow frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.Therapeutic apheresis in autoimmune diseases.Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.The pathology of T cells in systemic lupus erythematosusSystems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.Pathogenic mechanisms in systemic lupus erythematosus.Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.T-cell and B-cell signaling biomarkers and treatment targets in lupus.Analysis of the transcriptional program of developing induced regulatory T cellsCD8+ Tregs in lupus, autoimmunity, and beyond.The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunityBasophils and the T helper 2 environment can promote the development of lupus nephritis.Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian populationT cells as therapeutic targets in SLE.Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 micemTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus.Effects of cystamine on antioxidant activities and regulatory T cells in lupus-prone mice.Gimme shelter: the immune system during pregnancy.Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus.Compensatory T-cell regulation in unaffected relatives of SLE patients, and opposite IL-2/CD25-mediated effects suggested by coreferentiality modeling.Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
P2860
Q24615454-BB6A325F-6735-43E4-88B5-DA1F5A300329Q24625814-15C95DC5-D0B6-48ED-99FE-7A4108E10109Q24655393-8DEE0C49-6815-4C33-8D99-30AA7FC5FA88Q24656069-7F3BD95C-18C2-4ADA-9106-09AD7A907073Q26773124-C68550A6-B66E-42BE-9C3E-0157C7DF164FQ26795580-102C0496-0F41-48EB-A8A4-2116F4C7D0EAQ26801642-0D2E1743-246B-41B5-82F6-4E708A778410Q26991447-DF7DEA9D-DB40-4069-A473-264C71C352F2Q28067781-CC78A492-D34D-4824-B7AF-D02DA00C8E62Q28069199-EE23C169-B258-48C0-94CD-E8BD4F2E4772Q28507270-2E788C2A-A800-48EE-86B9-1126B8CDB1A6Q33403373-C7640993-D3BE-4F4E-BEBE-97FD15085F10Q33436347-21A1F813-358B-4322-9C4B-29B6D22CA7BCQ33473900-4126CB04-76AA-4CD2-A440-F1DCE499637AQ33598213-87F0B83A-DF48-4BDF-8691-E806B7FB09D5Q33608479-26A4F14A-16DA-46E3-B54A-38AB093CB25AQ33651557-6E1B9B33-E437-440B-B107-978A9CB909CCQ33682274-FE5D1B86-0574-41E2-A5A1-A4242C8A87C4Q33715441-96C4BF93-E748-4A37-B966-CD6ED9FBD9BDQ33715480-B410AE3F-1055-4703-A8A8-F50FCB23812BQ33718893-0B3E3745-CC7E-4A48-A91B-F08B450F4E98Q33828647-50A40862-D8DC-48D3-AD42-6BAA030914DFQ33889097-6A23738A-5FCA-4C02-9524-FC6291535D0BQ33961011-966DE6C6-0DF4-4C29-B341-C845A4758138Q34018381-8693DFE4-838F-4515-B3CA-485DC200DEA3Q34056359-62C60F7A-9A8F-41D6-A43D-1D818F58DA27Q34075552-45401AC2-04FF-45D7-BDFF-C2A9D7F2038FQ34098180-6D06E446-9C92-4825-A693-53C8A1E0BF61Q34107250-EBA3ED41-7E4F-48F7-9DC2-280D0F51D005Q34152960-15E47F8D-91D9-4D71-BD2A-F14C68C354CCQ34154776-0CF63B3D-4F03-49F7-9AA9-C649D6AE6B1BQ34177939-AA628757-6E87-4021-9AEB-ECD5ECA6B2E8Q34193132-5C19F226-1C52-4AC2-8978-B7BBDA9AE4C0Q34221885-41DFC74E-92AF-4B93-8397-88D81A9B18DFQ34233668-ECCF411C-75E2-4DDD-B1CF-B7E6DACC54A1Q34284885-A74EEA14-1871-4A79-B583-DF46001A53D1Q34361763-DA0961D2-3BD4-41F0-A19B-CBA6CEC21B67Q34401977-55FD9BCE-B21C-4C17-863D-67DF47787897Q34412837-9BBEB539-8177-4EF9-B24A-96689BDBCABCQ34449084-C0C2B126-468B-4DED-96E4-D1CD68D7B62E
P2860
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@ast
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@en
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@nl
type
label
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@ast
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@en
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@nl
prefLabel
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@ast
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@en
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@nl
P2093
P1476
Deficient CD4+CD25high T regul ...... systemic lupus erythematosus.
@en
P2093
Cheryl Yarboro
Gabor Illei
Peter E Lipsky
Xavier Valencia
P304
P356
10.4049/JIMMUNOL.178.4.2579
P407
P577
2007-02-01T00:00:00Z